Oncopeptides Competitors and Similar CompaniesClear all
Oncopeptides's competitors and similar companies include CureVac.
Founding Date | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 80 | Employees 82517% decrease |
Valuation ($) | Valuation ($) 42.4 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) kr71.1m (FY, 2025) | Revenue (est.) €535.2m (FY, 2024) |
Cost of goods | Cost of goods kr2.5m (FY, 2025) | Cost of goods €9.7m (FY, 2024) |
Gross profit | Gross profit kr72m (FY, 2025) | Gross profit €534.4m (FY, 2024) |
Net income | Net income (kr249.6m) (FY, 2025) | Net income €162.2m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company